title: Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab.
authors.affiliation: Department of Transplantation, Medical Academy of Latvia, Riga, Latvia. latgraft@latnet.lv
authors.forename: I
authors.initials: I
authors.lastname: Folkmane
authors.forename: J
authors.initials: J
authors.lastname: Bicans
authors.forename: D
authors.initials: D
authors.lastname: Amerika
authors.forename: S
authors.initials: S
authors.lastname: Chapenko
authors.forename: M
authors.initials: M
authors.lastname: Murovska
authors.forename: R
authors.initials: R
authors.lastname: Rosentals
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D000077552:Basiliximab; D016572:Cyclosporine / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000453:epidemiology / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011183:Postoperative Complications / Q000453:epidemiology / Q000517:prevention & control; D011239:Prednisolone / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D016572:Cyclosporine; D000077552:Basiliximab; D011239:Prednisolone; D009173:Mycophenolic Acid; D001379:Azathioprine